Vancouver, B.C., January 4th 2016 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - http://www.commodity-tv.net/c/mid,5428,Company_Updates/?v=296935) today announced that it has received a purchase order and deposit from Natural Nutrition, d.b.a. Nanuva Ingredients (“Nanuva”), for a small-scale commercial Radiant Energy Vacuum (“REV™”) machine. This is the third royalty bearing REV™ machine purchased by Nanuva and is scheduled for delivery in 2017.
Nanuva currently processes over thirty high quality fruit products using REV™ technology including maquiberries, blueberries, strawberries, rosehip, pineapple, grapes and cherries. As Nanuva grows their business, they plan to be a leader in the production of high-value, nutrient rich, nutraceutical ingredients.
Nanuva is one of six licensed royalty partners of EnWave currently producing fruit and vegetable products for commercial distribution. Each partner pays EnWave a royalty based on the total amount of REV™-dried product sold each quarter.
About Natural Nutrition d.b.a Nanuva Ingredients
Nanuva Ingredients aims to deliver one-hundred-percent natural (with no additives), healthy and safe products for the global ingredients industry, minimizing the loss of fresh fruits natural properties. Nanuva is strategically located near the fruit growing center in the Bíobío Region, in the south of Chile.
Currently, Nanuva is positioned as a leader in Agro-industrial innovation, using low temperature and high efficiency drying processes (REV™ technology) unique to the Latin American market. With this, Nanuva Ingredients is recognized by its customers as a dried fruit processor with colors, shapes, flavors and nutrients very similar to those of fresh fruit. Nanuva’s products are used as healthy ingredients in the snack food, functional food, nutraceutical and cosmetics industry. For more information on Nanuva Ingredients, please visit www.nanuva.cl.
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food and pharmaceutical sectors. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed seventeen royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.
EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:
1. nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour
2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
3. quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Dr. Tim Durance
President & CEO
For further information:
John Budreski, Executive Chairman at +1 (416) 930-0914
Brent Charleton, Senior Vice President, Business Development at +1 (778) 378-9616
Jeremy Hellman, Senior Associate
The Equity Group
+1 (212) 836-9626
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.